Redhill Biopharma Ltd(RDHL)

8.34+0.33+4.12%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
- Redhill Biopharma Ltd盘中异动下午盘股价大涨5.42%报8.65美元
  市场透视 · 10-19
  Redhill Biopharma Ltd盘中异动下午盘股价大涨5.42%报8.65美元
- Redhill Biopharma Ltd盘中异动急速下跌5.04%
  市场透视 · 10-02
  Redhill Biopharma Ltd盘中异动急速下跌5.04%
- Redhill Biopharma Ltd盘中异动股价大跌5.14%
  市场透视 · 09-27
  Redhill Biopharma Ltd盘中异动股价大跌5.14%
- Redhill Biopharma Ltd盘中异动快速上涨5.05%
  市场透视 · 09-24
  Redhill Biopharma Ltd盘中异动快速上涨5.05%
- Redhill Biopharma Ltd盘中异动下午盘股价大跌5.32%
  市场透视 · 09-19
  Redhill Biopharma Ltd盘中异动下午盘股价大跌5.32%
- Redhill Biopharma Ltd盘中异动股价大跌5.12%
  市场透视 · 09-17
  Redhill Biopharma Ltd盘中异动股价大跌5.12%
- Redhill Biopharma Ltd盘中异动早盘大幅拉升6.27%
  市场透视 · 09-16
  Redhill Biopharma Ltd盘中异动早盘大幅拉升6.27%
- Redhill Biopharma Ltd盘中异动股价大涨5.54%报11.34美元
  市场透视 · 09-13
  Redhill Biopharma Ltd盘中异动股价大涨5.54%报11.34美元
- Redhill Biopharma Ltd盘中异动早盘股价大跌5.10%
  市场透视 · 08-27
  Redhill Biopharma Ltd盘中异动早盘股价大跌5.10%
- Redhill Biopharma Ltd盘中异动快速拉升5.88%
  市场透视 · 08-26
  Redhill Biopharma Ltd盘中异动快速拉升5.88%
- Redhill Biopharma Ltd盘中异动临近午盘股价大跌5.56%
  市场透视 · 08-23
  Redhill Biopharma Ltd盘中异动临近午盘股价大跌5.56%
- Redhill Biopharma Ltd盘中异动股价大跌7.50%
  市场透视 · 08-22
  Redhill Biopharma Ltd盘中异动股价大跌7.50%
- Redhill Biopharma Ltd盘中异动早盘快速下挫8.81%
  市场透视 · 08-21
  Redhill Biopharma Ltd盘中异动早盘快速下挫8.81%
- Redhill Biopharma Ltd股价重挫15.29% 市值跌133.15万美元
  自选股智能写手 · 08-20
  Redhill Biopharma Ltd股价重挫15.29% 市值跌133.15万美元
- 美股异动 | Redhill(RDHL.US)大涨18% opaganib有望用于肥胖相关疾病
  智通财经 · 08-19
  美股异动 | Redhill(RDHL.US)大涨18% opaganib有望用于肥胖相关疾病
- Redhill Biopharma Ltd股价飙升18.92% 市值涨208.97万美元
  自选股智能写手 · 08-19
  Redhill Biopharma Ltd股价飙升18.92% 市值涨208.97万美元
- Redhill Biopharma Ltd盘中异动股价大跌5.95%
  自选股智能写手 · 08-16
  Redhill Biopharma Ltd盘中异动股价大跌5.95%
- Redhill Biopharma Ltd盘中异动大幅拉升5.42%报0.387美元
  自选股智能写手 · 08-14
  Redhill Biopharma Ltd盘中异动大幅拉升5.42%报0.387美元
- Redhill Biopharma Ltd盘中异动早盘股价大跌5.27%
  自选股智能写手 · 08-13
  Redhill Biopharma Ltd盘中异动早盘股价大跌5.27%
- Redhill Biopharma Ltd盘中异动下午盘股价大跌5.23%
  自选股智能写手 · 08-13
  Redhill Biopharma Ltd盘中异动下午盘股价大跌5.23%
公司概况
公司名称
Redhill Biopharma Ltd
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.redhillbio.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Redhill Biopharma Ltd.于2009年8月3日在以色列注册成立。该公司是一家专业生物制药公司，主要专注于胃肠道和传染病。该公司的主要目标是通过在美国的商业存在，成为一家领先的专业生物制药公司，支持在美国上市的现有和潜在的其他产品的商业化，以及未来可能的治疗候选药物的商业化（如果获得批准的话）。该公司目前主要致力于在美国实现GI相关产品Talicia（奥美拉唑、阿莫西林和利福布汀）和Aemcolo（利福霉素）的商业化。
- 08-16
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 06-20
  员工持股计划
  Form S-8 - Securities to be offered to employees in employee benefit plans
  Form S-8 - Securities to be offered to employees in employee benefit plans
- 04-08
  年度报告
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 02-15
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 02-09
  招股说明书
  Form F-1 - Registration statement for certain foreign private issuers
  Form F-1 - Registration statement for certain foreign private issuers
- 02-02
  超过5%披露
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
- 02-01
  超过5%披露
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
- 01-08
  超过5%披露
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
- 2023-10-26
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2023-08-10
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2023-06-29
  员工持股计划
  Form S-8 - Securities to be offered to employees in employee benefit plans
  Form S-8 - Securities to be offered to employees in employee benefit plans
- 2023-04-28
  年度报告
  20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 2023-01-13
  超过5%披露
  SC 13G - Statement of acquisition of beneficial ownership by individuals
  SC 13G - Statement of acquisition of beneficial ownership by individuals
- 2022-06-27
  员工持股计划
  S-8 - Securities to be offered to employees in employee benefit plans
  S-8 - Securities to be offered to employees in employee benefit plans
- 2022-03-17
  年度报告
  20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]